The Risk of Dystonia among Children and Adolescents Treated with Atomoxetine within the Truven MarketScan Database (B4Z-MC-B031)

24/03/2016
31/03/2024
EU PAS number:
EUPAS11221
Study
Finalised
Documents
Study protocol
Initial protocol
English (565.2 KB - PDF) View document
Study results
Study results
English (3.17 MB - PDF) View document
Study report
Other information
Publications